These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


186 related items for PubMed ID: 4592901

  • 1. Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.
    King OY, Wilbur JR, Mumford DM, Sutow WW.
    Cancer; 1974 Mar; 33(3):611-4. PubMed ID: 4592901
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli.
    Ohnuma T, Holland JF, Meyer P.
    Cancer; 1972 Aug; 30(2):376-81. PubMed ID: 4559405
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The "other" asparaginase.
    Hrushesky WJ, Slavik M, Penta J, Muggia F.
    Med Pediatr Oncol; 1976 Aug; 2(4):441-2. PubMed ID: 794672
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS, Kham SK, Ariffin H, Lin HP, Quah TC, Yeoh AE.
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. L-asparaginase in treatment of acute leukaemia and lymphosarcoma.
    Beard ME, Crowther D, Galton DA, Guyer RJ, Fairley GH, Kay HE, Knapton PJ, Malpas JS, Scott RB.
    Br Med J; 1970 Jan 24; 1(5690):191-5. PubMed ID: 4904933
    [Abstract] [Full Text] [Related]

  • 11. Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.
    Risseeuw-Appel IM, Dekker I, Hop WC, Hählen K.
    Med Pediatr Oncol; 1994 Jan 24; 23(4):335-43. PubMed ID: 8058004
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for the Escherichia coli enzyme preparation.
    Ridgway D, Neerhout RC, Bleyer A.
    Cancer; 1989 Feb 01; 63(3):561-3. PubMed ID: 2643458
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study.
    Wacker P, Land VJ, Camitta BM, Kurtzberg J, Pullen J, Harris MB, Shuster JJ, Children's Oncology Study Group.
    J Pediatr Hematol Oncol; 2007 Sep 01; 29(9):627-32. PubMed ID: 17805038
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA, Nesbit ME, Donaldson MH, Hittle RE, Weiner J, Karon M, Hammond D.
    Cancer Res; 1977 Feb 01; 37(2):535-40. PubMed ID: 264412
    [Abstract] [Full Text] [Related]

  • 20. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
    Kondrat'eva NA, Lorie IlI, Kruglova GV, Vorob'ev AI, Koshel' IV.
    Antibiotiki; 1977 Sep 01; 22(9):852-7. PubMed ID: 334060
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.